| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10157980 | Vaccine | 2018 | 6 Pages |
Abstract
Most women who received maternal HepB did not have high-risk indications for vaccination. No increased risk for the adverse events that were examined were observed among women who received maternal HepB or their offspring.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Holly C. Groom, Stephanie A. Irving, Padma Koppolu, Ning Smith, Gabriela Vazquez-Benitez, Elyse O. Kharbanda, Matthew F. Daley, James G. Donahue, Darios Getahun, Lisa A. Jackson, Alison Tse Kawai, Nicola P. Klein, Natalie L. McCarthy, James D. Nordin,